MX2012015059A - Composicion para mejorar el bienestar sexual. - Google Patents

Composicion para mejorar el bienestar sexual.

Info

Publication number
MX2012015059A
MX2012015059A MX2012015059A MX2012015059A MX2012015059A MX 2012015059 A MX2012015059 A MX 2012015059A MX 2012015059 A MX2012015059 A MX 2012015059A MX 2012015059 A MX2012015059 A MX 2012015059A MX 2012015059 A MX2012015059 A MX 2012015059A
Authority
MX
Mexico
Prior art keywords
source
sexual
arginine
welfare
composition
Prior art date
Application number
MX2012015059A
Other languages
English (en)
Spanish (es)
Inventor
Victor Ferrari
Carolina Burki
Frank Schoenlau
Original Assignee
Horphag Res Ip Pre Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horphag Res Ip Pre Ltd filed Critical Horphag Res Ip Pre Ltd
Publication of MX2012015059A publication Critical patent/MX2012015059A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MX2012015059A 2010-06-25 2011-06-24 Composicion para mejorar el bienestar sexual. MX2012015059A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34430110P 2010-06-25 2010-06-25
CH4702011 2011-03-21
PCT/IB2011/052788 WO2011161655A1 (en) 2010-06-25 2011-06-24 Composition for improving sexual wellness

Publications (1)

Publication Number Publication Date
MX2012015059A true MX2012015059A (es) 2013-04-03

Family

ID=44534509

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012015059A MX2012015059A (es) 2010-06-25 2011-06-24 Composicion para mejorar el bienestar sexual.

Country Status (15)

Country Link
US (1) US9028890B2 (enExample)
EP (1) EP2585088B1 (enExample)
JP (1) JP5819951B2 (enExample)
CN (1) CN103037883B (enExample)
BR (1) BR112012032632A2 (enExample)
CA (1) CA2803360C (enExample)
DK (1) DK2585088T3 (enExample)
ES (1) ES2498291T3 (enExample)
JO (1) JO2975B1 (enExample)
MX (1) MX2012015059A (enExample)
PT (1) PT2585088E (enExample)
SG (1) SG186369A1 (enExample)
TW (1) TWI494103B (enExample)
WO (1) WO2011161655A1 (enExample)
ZA (1) ZA201209725B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2793905E (pt) * 2011-12-23 2016-06-20 Horphag Res Ip (Qr) Ltd Composição de extratos ricos em elagitaninos no bem-estar sexual
FR3005262A1 (fr) * 2013-05-02 2014-11-07 Philippe Gorny Nouvelles compositions pharmaceutiques ou dietetiques permettant de masquer totalement l'amertume des sels d'arginine donnes a haute dose, sous forme liquide ou semi-liquide.
CN103392853B (zh) * 2013-07-08 2014-12-24 广西壮族自治区农业科学院蔬菜研究所 一种前列腺保健芥蓝茶及其制备方法
AU2014293314B2 (en) * 2013-07-22 2018-07-12 Ohio State Innovation Foundation Methods for reducing the occurrence of hot flashes
RU2600845C2 (ru) 2014-07-04 2016-10-27 Общество С Ограниченной Ответственностью "Консорциум-Пик" Применение производных оксатриазолий-5-олата для лечения сексуальных расстройств
GB201413228D0 (en) * 2014-07-25 2014-09-10 Nugerontix Ltd Polyphenol compositions
IL254568B2 (en) 2015-03-19 2023-11-01 Wendy Anne Epstein Catechin compounds extracted from tea leaves for the treatment of female sexual disorders
CN105520131A (zh) * 2015-12-09 2016-04-27 刘传新 一种男性性功能促进剂及其制备方法
TWI736755B (zh) 2017-04-03 2021-08-21 大江生醫股份有限公司 包含植物萃取物的組成物及其減少紫外線所致皮膚損傷之用途
US12090188B2 (en) * 2017-08-30 2024-09-17 Amare Global Nutritional supplements affecting gut-brain-axis balance and mental wellness
CN108041588A (zh) * 2017-12-08 2018-05-18 冯纪敏 一种含有海藻糖的组合物及其应用
WO2019157164A1 (en) * 2018-02-09 2019-08-15 Innovus Pharmaceuticals, Inc. Sensitization cream comprising l-arginine and l-citrulline and therapeutic uses thereof
AU2019264983B2 (en) * 2018-05-08 2025-03-27 Laila Nutra Private Limited Synergistic herbal compositions for testosterone boosting
CN108935685A (zh) * 2018-08-15 2018-12-07 新疆天健禾牧生物技术有限公司 一种提升雄性激素分泌的乳制品
DK180173B1 (en) 2018-12-07 2020-07-14 Inxo Ivs Compositions for improving sexual function
US11571405B2 (en) 2018-12-07 2023-02-07 Inxo A/S Compositions for improving sexual function
JP7460327B2 (ja) * 2019-03-19 2024-04-02 小林製薬株式会社 経口組成物
US10849948B2 (en) 2019-04-16 2020-12-01 The Procter & Gamble Company Supplement for menopause
US11723941B2 (en) 2019-09-04 2023-08-15 Amare Global Nutritional supplements and methods of supplementation affecting the endocannabinoid system
US11529387B2 (en) 2019-09-04 2022-12-20 Amare Global Nutritional supplements and methods of nutritional supplementation affecting global mood state
WO2021046396A1 (en) 2019-09-04 2021-03-11 Amare Global Nutritional supplements and methods of nutritional supplementation affecting mood and focus in children
RU2736932C1 (ru) * 2020-02-19 2020-11-23 Владимир Владимирович Плетнев Концентрат для получения препарата, обладающего днк-, ангио-, гепатопротекторным, иммуномодулирующим, антиоксидантным, антимикробным, противовоспалительным действием, и для производства воды, напитков, гелей и лосьонов-спреев для кожи и волос
JP2021066739A (ja) * 2021-01-28 2021-04-30 株式会社東洋新薬 血流改善組成物
CN116369525A (zh) * 2023-04-27 2023-07-04 江苏大学 一种缓解环磷酰胺生殖毒性的浆果组合物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1427100A (fr) 1964-12-14 1966-02-04 Ile De Rech Pharma Et Therapeu Procédé pour l'obtention d'hydroxyflavanne-3-4-diols
US5720956A (en) 1996-04-10 1998-02-24 Rohdewald; Peter Method of controlling the reactivity of human blood platelets by oral administration of the extract of the maritime pine (pycnogenol)
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
JP3260134B2 (ja) 1999-10-08 2002-02-25 信孝 鈴木 月経困難症、子宮内膜症の治療薬
US20040137081A1 (en) 2003-01-13 2004-07-15 Peter Rohdewald Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
WO2001089543A2 (en) 2000-05-26 2001-11-29 Horphag Research Limited Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion
IT1317036B1 (it) 2000-05-30 2003-05-26 Sigma Tau Healthscience Spa Integratore ad attivita' antiossidante comprendente unaalcanoilcarnitina ed una associazione di polifenoli estratti da piante
TWI282275B (en) * 2000-08-17 2007-06-11 Control Ox Oy Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections
JP4716655B2 (ja) * 2001-11-21 2011-07-06 ユニバーシティ・オブ・オーフース 抗炎症剤としてのモノ−およびジアシルグリセロールのグリコシドの使用
JP2004067590A (ja) * 2002-08-06 2004-03-04 Naris Cosmetics Co Ltd 女性ホルモン産生促進剤及びこれを含有する皮膚外用剤
TWI330529B (en) * 2003-01-13 2010-09-21 Horphag Res Luxembourg Holding Sa A preparation for improving sperm quality or fertility,a kit comprising the same and uses thereof
JP4499371B2 (ja) 2003-01-14 2010-07-07 株式会社 エフェクト 落花生由来のプロアントシアニジンの製造方法
ATE524483T1 (de) 2006-07-03 2011-09-15 Hyben Vital Licens Aps Verfahren zur herstellung eines glykosids eines mono- oder diacylglyzerinprodukts aus einem pflanzlichen material
RU2388811C2 (ru) 2007-01-24 2010-05-10 Общество с ограниченной ответственностью "Тюмень" Композиция ингредиентов для получения целебного бальзама
WO2008115583A1 (en) 2007-03-21 2008-09-25 John Mini Herbal treatments
US20080305096A1 (en) 2007-06-07 2008-12-11 Unicity International, Inc. Method and composition for providing controlled delivery of biologically active substances
WO2009053932A1 (en) * 2007-10-23 2009-04-30 Horphag Research (Luxembourg) Holding Sa Methods for improving female sexual function
CN101589802A (zh) * 2008-05-28 2009-12-02 程礼华 一种精卵子保健酒

Also Published As

Publication number Publication date
BR112012032632A2 (pt) 2016-11-22
JO2975B1 (en) 2016-03-15
DK2585088T3 (da) 2014-08-25
SG186369A1 (en) 2013-01-30
JP5819951B2 (ja) 2015-11-24
US9028890B2 (en) 2015-05-12
CA2803360A1 (en) 2011-12-29
EP2585088A1 (en) 2013-05-01
ES2498291T3 (es) 2014-09-24
EP2585088B1 (en) 2014-06-18
HK1182332A1 (en) 2013-11-29
PT2585088E (pt) 2014-09-03
WO2011161655A1 (en) 2011-12-29
JP2013530985A (ja) 2013-08-01
US20130164394A1 (en) 2013-06-27
TW201208671A (en) 2012-03-01
CN103037883B (zh) 2014-12-10
CN103037883A (zh) 2013-04-10
ZA201209725B (en) 2013-08-28
CA2803360C (en) 2020-03-24
TWI494103B (zh) 2015-08-01

Similar Documents

Publication Publication Date Title
MX2012015059A (es) Composicion para mejorar el bienestar sexual.
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
IN2012DN00624A (enExample)
EP4218743A3 (en) Compositions for use in cartilage breakdown
NZ707477A (en) Activin-actrii antagonists and uses for treating bone and other disorders
HK1221171A1 (zh) 用於刺激骨生长的组合物
MX2014004366A (es) Aceleracion de la recuperacion muscular despues de la atrofia muscular inducida por inmovilizacion.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
EA201390060A1 (ru) Аннелированные пиримидины и триазины и их применение для лечения и/или профилактики сердечно-сосудистых заболеваний
BR112014015354A2 (pt) composição de extratos enriquecidos com elagitaninos no bem-estar sexual
EP2316412A3 (en) High-clarity aqueous concentrates of 4-hexylresorcinol
MX2014005440A (es) Inhibidores de nicotinamida adenina dinucleotido difosfato oxidasa-4 y uso de los mismos.
MX2014008705A (es) Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos.
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
TN2015000255A1 (fr) Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
UA107687C2 (ru) Комбинированная композиция, которая в качестве активных ингредиентов содержит l-карнитин или пропионил-l-карнитин, троксерутин, диосмин и гесперидин, для предотвращения и/или лечения хронических заболеваний вен.
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
NZ754706A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
MX2018000092A (es) Nuevo lipolantipeptido biciclico, preparacion y uso como agente antimicrobiano.
IN2012DN03187A (enExample)
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
CL2017000884A1 (es) Composición farmacéutica para usarse en el tratamiento o la prevención de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugía de derivación gástrica
WO2011118957A3 (ko) 파프리카 추출물을 함유하는 염증, 알레르기 또는 천식 질환 치료용 조성물
TR200900881A2 (tr) Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler

Legal Events

Date Code Title Description
FG Grant or registration